Aceto Names New Head For Asian Sourcing Operations
Mr Mo joined Aceto in 1996 when he was hired to establish Aceto’s office and sourcing operations in China. Prior to that, Mr Mohe was the sales manager
Daiichi Sankyo and Merck & Co (MSD) have voluntarily withdrawn their biologics license application (BLA) for ifinatamab deruxtecan, aimed at treating adult patients with extensive-stage small cell lung cancer (ES-SCLC) following disease progression after platinum-based chemotherapy.
The HGCP Technology allows production of active pharmaceutical ingredient (API) at both low micron and nano-sized range. NMT has demonstrated the suitability of the technology for processing APIs
ChromoCure recently formed joint venture and technology sharing agreement with Genome Research Group, whose Therapeutic Modeling Protocols, together with ChromoCure’s Chromosomal Scanning Technology, further strengthens its leadership in